Deal Announcements

Alimera Sciences Receives 2nd Series B Tranche

Monday, November 27, 2006 7:00:00 AM PDT | VentureDeal Staff

ATLANTA, GA --  Alimera Sciences announced the receipt of the second and final tranche of its Series B financing.  The funding totaled $15.9 million and
brings Series B funding to-date to $31.8 million.

The company is developing ophthalmic pharmaceuticals and will use the funds to further develop it's stage III trial drug Medidur TM which the company claims treats diabetic macular edema.

All previous Series B investors participated in the tranche, including BA Venture Partners, Intersouth Partners, Domain Associates, Venrock Partners and Polaris Venture Partners.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1